Researchers have developed a tiny, flexible neural probe that can be implanted for longer time periods to record and stimulate neural activity, while minimizing injury to the surrounding tissue. The probe would be ideal for studying small and dynamic areas of the nervous system like the spinal cord.
UC San Diego engineers have developed a low cost, low power technology to help robots accurately map their way indoors, even in poor lighting and without recognizable landmarks or features. The technology uses WiFi signals, instead of light, to help the robot "see" where it’s going.
Every quarter, UC San Diego engineers Joshua Pelz and Luca De Vivo, as well as prosthetics specialist Herb Barrack, travel to Ensenada, Mexico, where they work with amputees to provide free, 3D-printed, custom-made prostheses.
UC San Diego researchers fared well in this year’s Multidisciplinary University Research Initiative (MURI) competition, held annually by the Department of Defense. The DOD has announced MURI awards for two UC San Diego-led research teams and three teams of which UC San Diego researchers are a part.
Franklin Antonio, a University of California San Diego alumnus from 1974, co-founder of Qualcomm and generous philanthropist, has died.
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.
On April 28, more than 100+ startups and business leaders convened in Petco Park to engage with the diversity, variety and ambition of the regional life sciences and technology startup scene. UC San Diego featured the largest representation of startups at the event.
Traumatic brain injuries might have faded from the headlines since the NFL reached a $765 million settlement for concussion-related brain injuries, but professional football players aren’t the only ones impacted by these injuries.
Bioengineers and cardiologists from UC San Diego invented a technology that can accurately and noninvasively map atrial and ventricular heart arrhythmias in a matter of minutes. The technology demonstrated 97.3 percent accuracy in a clinical validation study, and recently received FDA clearance.